SARS-CoV-2 neutralizing human antibodies protect against lower respiratory tract disease in a hamster model
Bart L Haagmans,
Nisreen M.A. Okba,
Rory de Vries,
Dennis de Meulder,
Peter van Run,
Mart M Lamers,
Frank J.M. van Kuppeveld,
Berend Jan Bosch,
Posted 24 Aug 2020
bioRxiv DOI: 10.1101/2020.08.24.264630
Posted 24 Aug 2020
Effective clinical intervention strategies for COVID-19 are urgently needed. Although several clinical trials have evaluated the use of convalescent plasma containing virus-neutralizing antibodies, the effectiveness has not been proven. We show that hamsters treated with a high dose of human convalescent plasma or a monoclonal antibody were protected against weight loss showing reduced pneumonia and pulmonary virus replication compared to control animals. However, a ten-fold lower dose of convalescent plasma showed no protective effect. Thus, variable and relatively low levels of virus neutralizing antibodies in convalescent plasma may limit their use for effective antiviral therapy, favouring concentrated, purified (monoclonal) antibodies. ### Competing Interest Statement A patent application has been filed for antibody 47D11 targeting SARS-CoV-2 (United Kingdom patent application no. 2003632.3; patent applicants: Utrecht University, Erasmus Medical Center and Harbour BioMed). Others declare no competing interests.
- Downloaded 1,959 times
- Download rankings, all-time:
- Site-wide: 7,997
- In microbiology: 455
- Year to date:
- Site-wide: 7,380
- Since beginning of last month:
- Site-wide: 34,698
Downloads over time
Distribution of downloads per paper, site-wide
- 27 Nov 2020: The website and API now include results pulled from medRxiv as well as bioRxiv.
- 18 Dec 2019: We're pleased to announce PanLingua, a new tool that enables you to search for machine-translated bioRxiv preprints using more than 100 different languages.
- 21 May 2019: PLOS Biology has published a community page about Rxivist.org and its design.
- 10 May 2019: The paper analyzing the Rxivist dataset has been published at eLife.
- 1 Mar 2019: We now have summary statistics about bioRxiv downloads and submissions.
- 8 Feb 2019: Data from Altmetric is now available on the Rxivist details page for every preprint. Look for the "donut" under the download metrics.
- 30 Jan 2019: preLights has featured the Rxivist preprint and written about our findings.
- 22 Jan 2019: Nature just published an article about Rxivist and our data.
- 13 Jan 2019: The Rxivist preprint is live!